Here's the live share price of Gennex Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Gennex Laboratories has gained 20.75% CAGR. Over the past year, the corresponding return has been -27.88%.
Gennex Laboratories’s current P/E of 13.84x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Gennex Laboratories | -2.38 | -15.19 | 2.83 | 0.47 | -27.88 | 27.44 | 20.75 |
| Sun Pharmaceutical Industries | 0.32 | 1.60 | 10.60 | 8.68 | 0.14 | 21.96 | 25.69 |
| Divi's Laboratories | -0.03 | -3.56 | 3.97 | -3.76 | 7.56 | 23.41 | 10.46 |
| Torrent Pharmaceuticals | -0.96 | -1.58 | 6.01 | 15.51 | 11.14 | 33.01 | 22.19 |
| Cipla | 0.56 | -2.53 | -3.96 | -0.40 | 3.24 | 10.95 | 13.84 |
| Dr. Reddy's Laboratories | 1.59 | 2.13 | -3.05 | -3.64 | 1.84 | 13.05 | 4.60 |
| Lupin | 2.66 | 2.83 | 3.87 | 8.55 | 3.12 | 42.53 | 16.80 |
| Zydus Lifesciences | -0.63 | -1.76 | -11.31 | -4.28 | -5.33 | 30.89 | 14.08 |
| Mankind Pharma | -1.74 | -6.00 | -17.85 | -10.30 | -20.70 | 14.01 | 8.18 |
| Aurobindo Pharma | 1.51 | -3.89 | 8.47 | 7.17 | -2.01 | 39.53 | 6.40 |
| Alkem Laboratories | 0.29 | -1.90 | 2.54 | 16.65 | 4.19 | 23.22 | 13.84 |
| Abbott India | -1.25 | -6.50 | -10.56 | -12.97 | -1.18 | 9.86 | 11.43 |
| Glenmark Pharmaceuticals | -0.48 | 4.17 | -4.83 | 17.52 | 28.48 | 67.13 | 30.30 |
| Laurus Labs | -0.88 | -1.28 | 12.95 | 52.78 | 76.64 | 37.55 | 24.16 |
| Biocon | 2.02 | -8.24 | 9.09 | 9.66 | 10.19 | 13.70 | -3.45 |
| GlaxoSmithKline Pharmaceuticals | -0.44 | 3.57 | -5.68 | -20.67 | 13.92 | 24.68 | 10.23 |
| Anthem Biosciences | 3.03 | -0.26 | -23.13 | -9.12 | -9.12 | -3.14 | -1.89 |
| Ipca Laboratories | -5.00 | -4.91 | 6.04 | 2.52 | -10.70 | 17.64 | 5.16 |
| Ajanta Pharma | -1.89 | 4.06 | 1.69 | 2.29 | -9.32 | 30.31 | 18.76 |
| J B Chemicals & Pharmaceuticals | -1.77 | -2.36 | 5.02 | 3.09 | -2.66 | 20.00 | 26.95 |
Over the last one year, Gennex Laboratories has declined 27.88% compared to peers like Sun Pharmaceutical Industries (0.14%), Divi's Laboratories (7.56%), Torrent Pharmaceuticals (11.14%). From a 5 year perspective, Gennex Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (25.69%) and Divi's Laboratories (10.46%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 13.06 | 13.02 |
| 10 | 13.31 | 13.21 |
| 20 | 13.66 | 13.56 |
| 50 | 14.15 | 13.74 |
| 100 | 13.16 | 13.56 |
| 200 | 13.18 | 13.81 |
In the latest quarter, Gennex Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 76.38% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Nov 14, 2025, 11:00 PM IST | Gennex Laboratories - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025 |
| Nov 14, 2025, 10:44 PM IST | Gennex Laboratories - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, |
| Nov 04, 2025, 8:32 PM IST | Gennex Laboratories - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And |
| Oct 13, 2025, 10:29 PM IST | Gennex Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 02, 2025, 4:42 AM IST | Gennex Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
Gennex Laboratories Ltd. is a Public Limited Listed company incorporated on 29/03/1990 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1990PLC011168 and registration number is 011168. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 94.58 Cr. and Equity Capital is Rs. 22.74 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Gennex Laboratories is ₹12.73 as on Dec 17, 2025.
The Gennex Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Gennex Laboratories is ₹309.27 Cr as on Dec 17, 2025.
Today’s highest and lowest price of Gennex Laboratories are ₹13.07 and ₹12.50.
The 52-week high/low is the highest and lowest price at which Gennex Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Gennex Laboratories is ₹19.00 and 52-week low of Gennex Laboratories is ₹10.84 as on Dec 17, 2025.
The Gennex Laboratories has shown returns of -1.16% over the past day, -15.19% for the past month, 2.83% over 3 months, -27.88% over 1 year, 27.44% across 3 years, and 20.75% over 5 years.
P/E ratio of and PB ratio of Gennex Laboratories are 13.84 and 1.70 on Dec 17, 2025. While the company gives a dividend yield of 0.00 per annum.